[ad_1]
SILVER SPRING, Md. –
The United States Food and Drug Administration alerts health care professionals and patients of a voluntary recall of several drugs containing valsartan, an active ingredient used to treat High Blood Pressure
This recall is due to an impurity, N-nitrosodimethylamine (NDMA), which has been found in the recalled products. However, not all products containing valsartan are recalled.
NDMA is clbadified as a probable carcinogen to humans – a substance that can cause cancer – according to the results of laboratory tests.
"The FDA is committed to maintaining our standard of excellence in safety and efficacy," said FDA Commissioner, Scott Gottlieb, MD "This includes our efforts to ensure the quality of medicines and the safe When we identify deficiencies in the quality of drugs and manufacturing problems that may create risks for patients, we commit ourselves to act quickly to alert the public and facilitate the removal of the products of the market. "
– As valsartan is prescribed in drugs intended for the treatment of serious diseases, patients who take drugs containing valsartan their drug until they have a replacement product.
– To determine if a specific product has been recalled, patients should look at the name of the drug and the name of the company on the label of their product. If the information is not on the bottle, patients should contact the pharmacy that administered the medication.
– If a patient takes one of the recalled medications, he must follow the recall instructions provided by the company in question. This information has been published on the FDA website
– Patients should also contact their healthcare professional (the pharmacist who prescribed the drug or the doctor who prescribes the medicine) if their drug is included in this reminder to discuss their treatment, which may include another valsartan product not affected by this recall or other treatment option.
Source link
